This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Arne Berthelmann
Senior Director Oligonucleotide R&D at Bachem AG
Speaker

Profile

Arne Berthelmann studied chemistry at the Humboldt University Berlin, Germany. He then joined the group of Prof. J. Eichler at the Friedrich-Alexander-University Erlangen, where he obtained his Ph.D. for designing and synthesizing peptide inhibitors and vaccines in 2014. In the same year he started his career as project chemist with Bachem in Switzerland. Arne took a position as team leader of the API CMC development group after a short while and later on as director of the CMC development unit, where he started to work on oligonucleotides focusing on innovative technologies. Since beginning of 2023 he is leading Bachem’s oligonucleotide R&D team as Sr. Director focusing on process development and research with still a special interest in innovative technologies.

Agenda Sessions

  • Bachem Spotlight Presentation

    12:05pm